Functional analysis of some members of this family have identified protein domains that are required for subcellular localization, protein-protein interactions, and cell signalling events which are the focus of this review paper.
Introduction
Paraneoplastic Ma Antigen (PNMA) family is represented by at least fifteen family members, and three of the family members, PNMA1-3, are known to be associated with the Paraneoplastic Disorder (PND) [1] [2] [3] [4] [5] [6] [7] [8] . Recent human genome sequence analysis has identified additional members that belong to this family and a total of nineteen family members are currently known to be encoded by the human genome [9, 10] The patients of PND associated with PNMA1-3 were reported to exhibit syndromes consisting of paraneoplastic limbic and brain stem encephalitis , production of auto-antibodies specific to PNMA 1, 2 or 3 as well as cancer [1, 3, [11] [12] [13] [14] [15] [16] . Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto-antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues [5, 17, 18] . Although the mechanism that contributes to development of PND is unclear, its likely to be associated with aberrant expressions of PNMA1, 2 or 3 in tumor cells originated from non-neuronal tissues, including lung, breast and testicular tumors, leading to the development of tumor immunity against PNMA1, 2, or 3 [19] [20] [21] [22] [23] [24] . In normal individuals, PNMA family members are predominantly expressed in the human brain, and testis, except for MOAP-1 (PNMA4), and CCDC8 which are ubiquitously expressed in many human tissues and higher MOAP-1 expression is detected in the human brain and heart [5, 8, [25] [26] [27] . Among the PNMA family members, MOAP-1 is the most extensively studied protein in the family. MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family [8, [28] [29] [30] [31] [32] [33] [34] [35] . Furthermore, MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand [28] [29] [30] [31] [36] [37] [38] [39] . Other than PND, genetic mutations of two other PNMA family members are known to be associated with restrictive human growth and mental retardation [25, 40] . This paper describes current information on some members of the PNMA family members that are relatively well characterized, including their roles in cancer and apoptotic signalling.
Chromosomal Localization and Gene Structure
PNMA family members are encoded by at least 15 genes localized to human chromosome 14 (PNMA1 and MOAP-1), chromosome 19 (PNMA8A-C, and CCDC8), chromosome 8 (PNMA2), and X chromosome (PNMA3, PNMA5, and PNMA6A, PNMA6B, PNMA6E, PNMA6F, PNMA7A, and PNMA7B, Table 1 ). In addition, three additional PNMA family members, PNMA6E, 6F, and 8C which are likely to be generated through gene duplication events, were identified after analysis of the human genome databases (GRCh37.p5, GRCh38.p10 [41] ). In addition, extensive annotations of the human genome database
(GRCh38.p10) has resulted in reclassification of some of the PNMA members, PNMA6C, and PNMA6D, as existing members of the PNMA family, PNMA6A, and PNMA6B, respectively (Table 1 , [42, 43] ), as well as identification of pseudogenes that do not belong to the PNMA family (Table 2) . Furthermore, among the PNMA gene family, PNMA6B is classified as unprocessed pseudogene without protein coding function [43] . It is interesting to know that although most PNMA family members are expressed from multiple exons, the coding sequences of PNMA family members are mostly encoded by a single exon (Table 1) , raising the possibility that the expression of PNMA family members may be regulated through other cellular mechanisms. Indeed, MOAP-1 is known to be regulated by miRNAs as well as proteasome pathway [30, 44, 45] .
Sequence Homology
PNMA family members share high protein sequence homology with the highest sequence homology of 84% between PNMA7A and PNMA7B ( Figure 1 ). The lowest protein sequence homology of 9.5% is between PNMA7A and CCDC8 ( (Figure 2-3 ). In addition, a region rich in Lysine and Arginine basic residues, and designated as KRs is found in the protein sequences of all the members of PNMA family, except PNMA8B, and PNMA8C. Furthermore, it is interesting to know that PNMA family members share sequence homology at a poly-glutamic acid rich region (PolyE) near the C-terminus, except PNMA6F, 8A, and 8C ( Figure 3A-B) . Beyond the poly-glutamic acid rich region is the Cterminus with varying length and low sequence homology (variable C-terminal sequence, VCS) that can be identified in the protein sequences among the PNMA family members.
Nuclear targeting signal of PNMA5 was identified in the VCS region of PNMA5, PNMA7A
and PNMA7B ( Figure 3A-B) . From the sequence analysis, PNMA family members are conserved in quite a number of species, including rat, mouse, monkey, and chimpanzee [4, 41] . Further sequence analysis has shown that PNMA family members are conserved in chimpanzee and mouse with the lowest and highest amino acid sequence identity between
56% and 99% ( 
Protein-Protein Interactions

Interaction with Bcl-2 family Members
MOAP-1, also known as MAP-1, is the most extensively studied protein in the family. C-terminal domain (α6-α8) of Bax [54, [58] [59] [60] [61] [62] . Once exposed, Bax BH3 and the C-terminal domains engage neighbouring Bax monomer to generate Bax dimers, and oligomers [49, 58, 59, 62] . Furthermore, change in the Bax conformation enables C-terminus of Bax (α9) to be associated with mitochondrial membrane, effectively anchoring Bax oligomers to
mitochondria, leading to mitochondrial dysfunction and release of mitochondrial cytochrome C [58, 59] . Although required for binding to Bax, deletion mapping studies have shown that the BH3-like domain of MOAP-1 is not required for MOAP-1 to interact with Bcl-XL, which interacts with the N-and C-terminal regions of MOAP-1 [8, 32, 34] . Due to its pro-apoptotic activity, Bax is known to be frequently mutated in cancer cells [63] [64] [65] [66] .
Interaction with transcription factors and growth factors
Other than MOAP-1, PNMA7A (ZCCHC12, SIZN1) which shares 32% amino acid sequence identity with MOAP-1 was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP [43] .
Other than BMP cell signalling, PNMA7A was identified as transcriptional co-activator that interacts with c-Jun and activates AP-1 and CREB signalling [67] . Like many members of PNMA family, PNMA7A was found to be predominantly expressed in mouse brain, including cholinergic neurons as well as testis, pointing to the possibility that PNMA7A
could play an important role in the developmental regulation or maintenance of neuronal cells [68] . In addition, mutations of PNMA7A were found to be associated with human mental retardation [40, 69] . Currently, it's not clear whether PNMA7A plays a role in neuronal survival or apoptosis; however, recent studies showed that PNMA7A functions as an oncogene and the expression is elevated in thyroid cancer cells [70, 71] , suggesting than PNMA7A could function to promote neuronal and cancer cell growths. The coiled coil domain containing molecule, CCDC8, was one of the candidate genes identified to play a crucial role in human growth. Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome [25, 72] . Other than CCDC8 mutations in two other human genes, CUL7 and OBSL1, were also reported to be the important contributing factors of 3M-syndrome [72] . Interestingly, OBSL-1 was found to be the common protein interacting partner of both CCDC8 and CUL7, suggesting that the molecules might participate in common cell signalling pathway that regulate human growth [25] . In fact, patients with 3-M syndrome were found to exhibit growth hormone deficiency or disordered growth factor signalling [73, 74] . Furthermore, protein expression studies showed that CCDC8 protein level is relative low in tumour cells, and over-expression of CCDC8 in cancer cells inhibits invasiveness and metastasis of cancer cells [75] .
Interaction with death receptors associated signalling molecules and RASSF family members
Other than interacting with Bcl-2 family members, MOAP-1 was reported to be associated with RASSF1A, and RASS6 [29, [76] [77] [78] . RASSF1A is a tumor suppressor and its protein expression is frequently silenced in many cancer cells through hyper-methylation of its gene promoter [37, [79] [80] [81] [82] [83] [84] . Deletion and site directed mutagenesis studies showed that MOAP-1 interacts with poly-glutamic acid residues of RASSF1A [30, 85, 86] . In addition, MOAP-1 was shown to interact with RASSF1A, and TNF-R through its RASSF1A binding domain within the KRs region and poly-glutamic acid rich residues (polyE) of its C-terminus, respectively. Other than interacting with TNF-R1, MOAP-1 was reported to interact with TRAIL-R1 [86] . MOAP-1 was reported to be present in an inactive conformation through intramolecular interaction, and by interacting with RASSF1A, MOAP-1 is unfolded with its 
Protein-protein interaction among the PNMA family members
In addition, MOAP-1 was reported to interact with its family members, including PNMA2, and PNMA5 [46, 47] . Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1.
Furthermore, although sharing relatively high sequence homology, interaction between MOAP-1 and PNMA1 was not detectable in co-immunoprecipitation studies [46] . In addition, it is likely that PNMA family members may interact with other cellular proteins that modulate its activity or promote activation of activity that leads to stimulation of cell growth such as the aberrantly expressed PNMA1-3 in cancer cells (Figure 4 ).
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Protein Domains and Cell Signalling
Apoptosis Signalling of PNMA family members
Although MOAP-1 (PNMA4) was reported to mediate apoptosis by interacting with Bcl-2 family members, and RASSF protein isoforms, other PNMA family members are not known to be associated with these molecules, suggesting functional divergence among the PNMA family members [8, 32] . Similar to MOAP-1, PNMA1 was reported to mediate apoptotic cell death of cerebellar granule neurons (CGN) , which requires the N-terminal region of PNMA1 containing a BH3-like domain [6, 89] . However, the BH3-like domain of PNMA1 is not known to be associated with pro-apoptotic Bax, and it is possible that it may interact with an un-identified member of the Bcl-2 family as apoptosis mediated by PNMA1 can be inhibited by over-expression of Bcl-2 in the neuronal cells even no direct interaction between PNMA1 and Bcl2 has been observed, suggesting that Bcl2 indirectly inhibits PNMA1 by sequestering the BH3-like
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8 domain-binding molecule of PNMA1 [89] . Further evidence shows that PNMA1 expression is elevated in the striatum of mouse model of Huntington's disease, suggesting that PNMA1 expression plays an important role in neuro-degeneration by inducing neuronal cell death in
Huntington's disease model [89] . The nuclear localization signal (NLS) of PNMA7A plays an important role for protein translocation to nucleus where PNMA7A was reported to function as transcriptional activator by interacting with Smad1 and CBP in BMP mediated cell signalling [25] . In addition, PNMA7A was found to activate AP-1 and CREB, and interacts with C-Jun through its nuclear targeting function [67] .
Anti-apoptosis cell signalling and cancer
PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis [5, 14, 15, 46, [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] . However, other than closely associated with paraneoplastic disease, the molecular function of PNMA2 remains unclear. In order to identify the potential function of PNMA2, over-expression studies were conducted which showed that unlike PNMA1 and MOAP-1, over-expressed PNMA2 failed to promote apoptotic signalling in transfected MCF- is required for nuclear localization of PNMA5. Both the N-terminal and C-terminal domains of PNMA5 are required for apoptotic signalling in cancer cells [47] . Other than PNMA5, functional characterization of CCDC8 showed that over-expressed CCDC8 inhibited invasiveness of A549 cells while CCDC8 knock-downed cells promoted invasiveness of the cancer cells in cell migration assay [75] , suggesting that CCDC8 is a pro-apoptotic protein. In contrast, ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12
knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay [70, 71] , providing further evidence to support that ZCCHC12 functioned as an oncogene in papillary thyroid cancer [71] .
Regulation of PNMA family Members
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Regulation by ubiquitination and protein degradation
MOAP-1 has a short half-life of 25 min and the stability of the protein is regulated through ubiquitin proteasome pathway in which degradation of MOAP-1 occurred at G1, and S-G2 phases of cell cycle by the APC/C Cdh1 and the UBR5 ubiquitin ligases, respectively [101] [102] [103] . In contrast, Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/C Cdh1 -mediated ubiquitination and degradation [104, 105] . Due to its short half-life, the endogenous level of MOAP-1 in cancer cell lines was shown to be relatively low; however, MG-132, a proteasome inhibitor, could significantly enhance the stability and level of MOAP-1 protein in cancer cells [103] .
Regulation by miRNA
Although the exact mechanism has not been identified, MOAP-1 protein level was enhanced or stabilized in the cancer cells when treated with chemo-drugs or apoptosis stimuli [103] .
One possible explanation for stabilization of MOAP-1 during drug-induced apoptosis in cancer cells is the down-regulation of miRNA-1228 expression level during drug treatment [44] . miRNA-1228 negatively regulates MOAP-1 expression by binding to the miRNA target sequence of the MOAP-1 mRNA, and down-regulation of miRNA-1228 was shown to promote MOAP-1 stabilization [44] . Similarly, miR-25 has been reported to promote cell proliferation by promoting down-regulation of MOAP-1 expression in lung cancer [45] .
Regulation by other mechanisms
In addition, MOAP-1 may be regulated by phosphorylation as several phosphorylation sites have been identified in MOAP-1 protein sequence [29] . Analysis of MOAP-1 gene led to the identification of CpG island located near the gene promoter of MOAP-1, pointing to the possibility that MOAP-1 might be regulated through hyper-methylation of its gene promoter [106] . Other than gene expression regulation, pro-apoptotic activity of MOAP-1 was reported to be regulated by members of PNMA family. Co-expression of MOAP-1 with PNMA2 resulted in inhibition of pro-apoptotic activity of MOAP-1 in transiently transfected cancer cells [46] . Interestingly, PNMA2 has been shown to antagonize both pro-apoptotic activities of MOAP-1 and PNMA1 through heterodimeric interaction with MOAP-1 and PNMA1 [46] .
In contrast, co-expression of MOAP-1 with PNMA5 significantly enhanced pro-apoptotic activity of MOAP-1 in transfected cancer cells [47] . Similar to MOAP-1, CCDC8 was found
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A C C E P T E D M A N U S C R I P T 10 to be hyper-methylated or epigenetically silenced in breast tumors that showed metastasis potential [107] . In addition, CCDC8 knock-downed cancer cells showed increase in migration potential when tested in cell migration assay [75] . Regulation of other PNMA family members is currently unknown.
Concluding Remarks
PNMA family is represented by at least fifteen family members encoded by the human genome, and many family members share relatively conserved amino acid sequences near the N-terminal domain, whereas the C-terminal domain of some of the family members are functionally diverse, which includes nuclear localization signal and DNA binding domain. Table 2 shows the new locations of 5 PNMA family members reported by Iwasaki et al. (2013) . From sequence analysis, it was unearthed that hsPNMAs 7, 8 and 16, reported by the earlier group, are indeed, PNMAs. However, as can be seen from the table, they are already known by other aliases, namely 6F, 6E and 8C, respectively. The query length of the PNMAs covered while doing a BLAT analyses of the sequences located in GRCh37.p5 showed 100% match (identity) with those of the repositioned PNMAs, thereby validating that the genes encode additional PNMA family members which are likely to be generated through gene duplication events. However, the earlier reported hsPNMA 9 and 16, are found to be not belonging to the PNMA family. In fact, the earlier PNMA9 has been now found to be an unprocessed pseudogene AC243591.1. Similarly, PNMA16 reported earlier has now been mapped onto AC011551.1, an unprocessed pseudogene. 
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